` LN5 (Lannett Company Inc) vs DAX Index Comparison - Alpha Spread

L
LN5
vs
D
DAX Index

Over the past 12 months, LN5 has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +22% growth.

Stocks Performance
LN5 vs DAX Index

Loading
LN5
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
LN5 vs DAX Index

Performance Gap Between LN5 and GDAXI
HIDDEN
Show

Performance By Year
LN5 vs DAX Index

Loading
LN5
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Lannett Company Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Lannett Company Inc
Glance View

Market Cap
24.3m EUR
Industry
Pharmaceuticals

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. The company is headquartered in Trevose, Pennsylvania and currently employs 812 full-time employees. The company went IPO on 2002-04-15. The firm's products include Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; Posaconazole DR Tablets, which are used to prevent fungal infections in people; Verapamil SR tablets are a calcium channel blocker used in the treatment of high blood pressure, arrhythmia and angina; Methylphenidate CD Capsules used for the treatment of Attention Deficit Hyperactivity Disorder; Omeprazole Capsules, which is indicated for the treatment of certain diseases of the esophagus and stomach ulcers; Pantoprazole Sodium DR Tablets, which is a proton pump inhibitor, indicated for the treatment of certain diseases of the esophagus and pathological hypersecretory conditions; and Sumatriptan Nasal Spray, which is indicated for the acute treatment of migraine attacks.

LN5 Intrinsic Value
Not Available
Back to Top